Generex Announces Sales Agreement with Elias Shaker & Company (GNBT)
Generex Biotechnology Corporation (Nasdaq: GNBT) today announced that it has entered into a sales agreement with Elias Shaker & Company to represent Generex's novel consumer products to national and regional retail and wholesale accounts in the USA.
Generex is engaged in the research, development and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.